[{"@context":"https:\/\/schema.org\/","@type":"Article","@id":"https:\/\/www.zopz.sk\/blues-dala-55-milionov-dolarov-na-prevzatie-vyrobcov-generickych-liekov\/#Article","mainEntityOfPage":"https:\/\/www.zopz.sk\/blues-dala-55-milionov-dolarov-na-prevzatie-vyrobcov-generickych-liekov\/","headline":"Blues dala 55 mili\u00f3nov dol\u00e1rov na prevzatie v\u00fdrobcov generick\u00fdch liekov","name":"Blues dala 55 mili\u00f3nov dol\u00e1rov na prevzatie v\u00fdrobcov generick\u00fdch liekov","description":"Skupina pois\u0165ovate\u013eov v spolo\u010dnosti Blue Cross Blue Shield investuje 55 mili\u00f3nov dol\u00e1rov do podniku, ktor\u00e9ho cie\u013eom je pon\u00faknu\u0165 svojim \u010dlenom…","datePublished":"2020-01-16","dateModified":"2023-04-28","author":{"@type":"Person","@id":"https:\/\/www.zopz.sk\/author\/#Person","name":"","url":"https:\/\/www.zopz.sk\/author\/","identifier":1,"image":{"@type":"ImageObject","@id":"https:\/\/secure.gravatar.com\/avatar\/92dd6dcbda4dc4d3f89fcc9fa0e3d3cb?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/92dd6dcbda4dc4d3f89fcc9fa0e3d3cb?s=96&d=mm&r=g","height":96,"width":96}},"publisher":{"@type":"Organization","name":"zopz.sk","logo":{"@type":"ImageObject","@id":"\/logo.png","url":"\/logo.png","width":600,"height":60}},"image":{"@type":"ImageObject","@id":"https:\/\/www.zopz.sk\/wp-content\/uploads\/img_a309854_w16884_t1580312827.png","url":"https:\/\/www.zopz.sk\/wp-content\/uploads\/img_a309854_w16884_t1580312827.png","height":0,"width":0},"url":"https:\/\/www.zopz.sk\/blues-dala-55-milionov-dolarov-na-prevzatie-vyrobcov-generickych-liekov\/","about":["Tovar"],"wordCount":407,"articleBody":"Skupina pois\u0165ovate\u013eov v spolo\u010dnosti Blue Cross Blue Shield investuje 55 mili\u00f3nov dol\u00e1rov do podniku, ktor\u00e9ho cie\u013eom je pon\u00faknu\u0165 svojim \u010dlenom lacnej\u0161ie ceny za generick\u00e9 lieky, ktor\u00e9 v s\u00fa\u010dasnosti nemaj\u00fa mal\u00fa alebo \u017eiadnu konkurenciu, uviedla firma vo \u0161tvrtok. Zdru\u017eenie Blue Cross Blue Shield a 18 zdravotn\u00fdch pois\u0165ovate\u013eov BL spolupracuj\u00fa s Civica Rx, neziskovou firmou vytvorenou pred dvoma rokmi, aby sa pok\u00fasila zv\u00fd\u0161i\u0165 konkurenciu o generick\u00e9 lieky zalo\u017een\u00e9 na nemocniciach. Nov\u00e1 dc\u00e9rska firma sa zameria na lieky, ktor\u00e9 si \u010dlenovia m\u00f4\u017eu k\u00fapi\u0165 prostredn\u00edctvom z\u00e1sielkov\u00e9ho predaja alebo v lek\u00e1r\u0148ach. Po\u010dn\u00fac rokom 2022 pl\u00e1nuje za\u010da\u0165 pred\u00e1va\u0165 nov\u00fdch konkurentov za pribli\u017ene 7 a\u017e 10 drah\u00fdch generick\u00fdch liekov, ktor\u00e9 v s\u00fa\u010dasnosti maj\u00fa len jedn\u00e9ho v\u00fdrobcu, uviedol predseda Civica Dan Liljenquist. Lieky vyberie poradn\u00e1 rada. Civica bude schopn\u00e1 pred\u00e1va\u0165 lieky za ni\u017e\u0161iu cenu ako s\u00fa\u010dasn\u00fd v\u00fdrobca vyu\u017eit\u00edm objemu receptov medzi svojimi \u010dlenmi BL pl\u00e1nuje zaru\u010di\u0165 z\u013eavy, Liljenquist povedal. Organiz\u00e1cia m\u00f4\u017ee tie\u017e vyr\u00e1ba\u0165 lieky. \u010clenovia bud\u00fa ma\u0165 z t\u00fdchto ni\u017e\u0161\u00edch cien \u00fa\u017eitok na z\u00e1klade ich pl\u00e1nu, uviedla \u0161\u00e9fka strat\u00e9gie BCBSA Maureen Sullivan. Ni\u017e\u0161ie n\u00e1klady na pl\u00e1ny by sa mohli prejavi\u0165 v ni\u017e\u0161\u00edch v\u00fddavkoch mimo kapsu, \u00faspor\u00e1ch na celkovom poistnom alebo mo\u017enom zn\u00ed\u017een\u00ed spolu\u00fa\u010dasti alebo odpusten\u00ed spolu\u00fa\u010dasti pre pacientov, povedala. Pribli\u017ene 78% z 335 mili\u00e1rd dol\u00e1rov ro\u010dn\u00fdch v\u00fddavkov na drogy v USA ide na generick\u00e9 verzie zna\u010dkov\u00fdch medic\u00edn, ktor\u00e9 stratili patentov\u00fa ochranu, uv\u00e1dza skupina pre obchod s generick\u00fdmi v\u00fdrobkami. Ve\u013ek\u00ed v\u00fdrobcovia generick\u00fdch medic\u00edn tvrdia, \u017ee cenov\u00e1 konkurencia v\u00fdrazne oslabila zisky mnoh\u00fdch medic\u00edn, \u010do viedlo k konsolid\u00e1cii priemyslu. Zv\u00fd\u0161il sa tak po\u010det drog iba u jedn\u00e9ho v\u00fdrobcu, \u010do m\u00f4\u017ee vies\u0165 k v\u00fdrazn\u00fdm cenov\u00fdm \u0161pi\u010dk\u00e1m drog na z\u00e1chranu \u017eivota. Niektor\u00e9 mimoriadne z\u00e1va\u017en\u00e9 ned\u00e1vne pr\u00edklady dr\u00e1\u017edenia cien alebo nedostatku drog viedli americk\u00fa vl\u00e1du pre potraviny a lie\u010div\u00e1 k prijatiu nov\u00fdch polit\u00edk s cie\u013eom zjednodu\u0161it postup schva\u013eovania nov\u00fdch konkuren\u010dn\u00fdch generick\u00fdch medic\u00edn, ak s\u00fa k dispoz\u00edcii iba jedna alebo dve existuj\u00face verzie.                                                                                                                                                                                                                                                                                                                                                                                        4.7\/5 - (7 votes)        "},{"@context":"https:\/\/schema.org\/","@type":"BreadcrumbList","itemListElement":[{"@type":"ListItem","position":1,"name":"Blues dala 55 mili\u00f3nov dol\u00e1rov na prevzatie v\u00fdrobcov generick\u00fdch liekov","item":"https:\/\/www.zopz.sk\/blues-dala-55-milionov-dolarov-na-prevzatie-vyrobcov-generickych-liekov\/#breadcrumbitem"}]}]